Cardinal Health dba Specialty Pharmaceutical Services recalls Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only, Rx Only, Manufactur
Recalled October 2, 2019 · FDA recall D-1876-2019 · Cardinal Health
Hazard
Temperature Abuse; Product stored and shipped outside of labeled storage requirements. · FDA Class II
Units
38 syringes
Sold at
Nationwide in the U.S.
Description
Temperature Abuse; Product stored and shipped outside of labeled storage requirements.
Product
Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only, Rx Only, Manufactured by GlaxoSmithKline LLC, Philadelphia, PA 19112, Distributed by GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0892-42.
Manufacturer(s)
Cardinal Health dba Specialty Pharmaceutical Services
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →